CVE-2022-38094

Description

OS command injection vulnerability in the telnet function of CentreCOM AR260S V2 firmware versions prior to Ver.3.3.7 allows a remote authenticated attacker to execute an arbitrary OS command.

Category

8.8
CVSS
Severity: High
CVSS 3.1 •
EPSS 1.57% Top 20%
Vendor Advisory co.jp
Affected: Allied Telesis K.K. CentreCOM AR260S V2
Published at:
Updated at:

References

Link Tags
https://www.allied-telesis.co.jp/support/list/faq/vuls/20220829.html mitigation vendor advisory
https://jvn.jp/en/jp/JVN45473612/index.html third party advisory mitigation

Frequently Asked Questions

What is the severity of CVE-2022-38094?
CVE-2022-38094 has been scored as a high severity vulnerability.
How to fix CVE-2022-38094?
To fix CVE-2022-38094, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-38094 being actively exploited in the wild?
It is possible that CVE-2022-38094 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-38094?
CVE-2022-38094 affects Allied Telesis K.K. CentreCOM AR260S V2.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.